XML 52 R35.htm IDEA: XBRL DOCUMENT v3.25.0.1
Equity
 12 Months Ended
Dec. 31, 2024
Stockholders' Equity Note [Abstract]  
Equity

Note 23. Equity

 

2018 Share Repurchase Program

 

On August 1, 2018, the Company’s board of directors approved a share repurchase program authorizing the purchase of shares of Chemours’ issued and outstanding common stock in an aggregate amount not to exceed $750, plus any associated fees or costs in connection with the Company’s share repurchases activity (the “2018 Share Repurchase Program”). On February 13, 2019, the Company’s board of directors increased the authorization amount of the 2018 Share Repurchase Program from $750 to $1,000. Under the 2018 Share Repurchase Program, shares of Chemours’ common stock can be purchased in the open market from time to time, subject to management’s discretion, as well as general business and market conditions. On May 19, 2022, the Company completed the aggregate $1,000 in authorized purchases of Chemours’ issued and outstanding common stock under the 2018 Share Repurchase Program, which amounted to a cumulative 28,603,784 shares purchased at an average share price of $34.96 per share. All common shares purchased under the 2018 Share Repurchase Program are held as treasury stock and accounted for using the cost method.

 

The following table sets forth the Company’s share repurchase activity under the 2018 Share Repurchase Program for the years ended December 31, 2024, 2023 and 2022.

 

 

Year Ended December 31,

 

 

2024

 

 

2023

 

 

2022

 

Total number of shares purchased

 

—

 

 

 

—

 

 

 

7,824,039

 

Total paid for shares purchased

$

—

 

 

$

—

 

 

$

251

 

Average price paid per share

$

—

 

 

$

—

 

 

$

32.06

 

 

2022 Share Repurchase Program

 

On April 27, 2022, the Company’s board of directors approved a share repurchase program authorizing the purchase of shares of Chemours’ issued and outstanding common stock in an aggregate amount not to exceed $750, plus any associated fees or costs in connection with the Company’s share repurchase activity (the “2022 Share Repurchase Program”). Under the 2022 Share Repurchase Program, shares of Chemours’ common stock can be purchased in the open market from time to time, subject to management’s discretion, as well as general business and market conditions. The Company’s 2022 Share Repurchase Program became effective on April 27, 2022 and is scheduled to continue through the earlier of its expiration on December 31, 2025 or the completion of repurchases up to the approved amount. The program may be suspended or discontinued at any time. All common shares purchased under the 2022 Share Repurchase Program are expected to be held as treasury stock and accounted for using the cost method.‌

 

The following table sets forth the Company’s share repurchase activity under the 2022 Share Repurchase Program for the years ended December 31, 2024, 2023 and 2022.

 

 

Year Ended December 31,

 

 

2024

 

 

2023

 

 

2022

 

Total number of shares purchased

 

—

 

 

 

2,108,408

 

 

 

8,234,314

 

Total paid for shares purchased

$

—

 

 

$

69

 

 

$

241

 

Average price paid per share

$

—

 

 

$

32.48

 

 

$

29.24

 

 

Through December 31, 2024, the Company purchased a cumulative 10,342,722 shares of Chemours’ issued and outstanding common stock under the 2022 Share Repurchase Program, which amounted to $309 at an average share price of $29.90 per share. The aggregate amount of Chemours’ common stock that remained available for purchase under the 2022 Share Repurchase Program at December 31, 2024 was $441, though the Company does not anticipate additional repurchases under the 2022 Share Repurchase Program.